The prognosis for endocrine-independent prostate carcinoma is still poor due to its highly metastatic feature. In the present work, TPX2 (the targeting protein for Xklp2), which is known as a micro-tubulin interacted protein, was identified as a novel coactivator of ETS-1, a transcription factor that plays a central role in mediating the metastasis of human malignancies. TPX2 enhanced the transcription factor activation of ETS-1 and increased the expression of ETS-1's downstream metastasis-related genes, such as or , induced by HGF (hepatocyte growth factor), a typical agonist of the HGF/c-MET/ETS-1 pathway. The protein-interaction between TPX2 and ETS-1 was examined using immunoprecipitation (IP). TPX2 enhanced the accumulation of ETS-1 in the nuclear and the recruitment of its binding element (EST binding site, EBS) located in the promoter region of its downstream gene, . Moreover, TPX2 enhanced the or invasion of a typical endocrine-independent prostate carcinoma cell line, PC-3. Therefore, TPX2 enhanced the activation of the HGF/ETS-1 pathway to enhance the invasion of endocrine-independent prostate carcinoma cells and thus it would be a promising target for prostate carcinoma treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193931 | PMC |
| http://dx.doi.org/10.3389/fonc.2021.618540 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
HURP facilitates spindle assembly by stabilizing microtubules and working synergistically with TPX2.
Nat Commun
November 2024
Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
Article Synopsis
- Most vertebrate spindles utilize branching microtubule nucleation, where new microtubules form alongside existing ones.
- The study highlights the role of hepatoma up-regulated protein (HURP) in this process, showing it is essential for RanGTP-induced microtubule branching in Xenopus egg extract.
- HURP stabilizes the microtubule structure and shifts its function toward facilitating branching by localizing to TPX2 condensates, which are crucial for spindle assembly, supported by high-resolution cryo-EM imaging of HURP on microtubules.
TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality.
Gut
November 2024
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
Article Synopsis
- PARP inhibitors have been approved for maintenance therapy in metastatic pancreatic cancer patients with rare BRCA1/2 mutations, highlighting a significant unmet need for broader applications.* -
- Research involved RNA sequencing to identify potential targets for PARPi sensitivity, verifying that targeting TPX2 can increase vulnerability to these inhibitors and promote synthetic lethality in various cancer models.* -
- TPX2 plays a crucial role in the DNA repair process, and manipulating its phosphorylation status enhances PARPi sensitivity and contributes to genomic instability, suggesting that combining TPX2 inhibition with other therapies like gemcitabine could improve treatment effectiveness.*
Citrinin disrupts microtubule assembly in cardiac cells: Impact on mitochondrial organization and function.
Chemosphere
October 2024
Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address:
Citrinin (CTN) is a mycotoxin commonly present in various foods and feeds worldwide, as well as dietary supplements in Asian countries, but the risks and cellular mechanisms associated with its cardiotoxicity remains unclear. In this study, RNA-seq analysis of CTN-treated H9c2 cardiac cells demonstrated significant perturbations in pathways related to microtubule cytoskeleton and mitochondrial network organization. CTN disrupted microtubule polymerization and downregulated mRNA levels of microtubule-assembling genes, Map2 and Tpx2, in H9c2 cardiac cells.
View Article and Find Full Text PDFA novel super-enhancer-related risk model for predicting prognosis and guiding personalized treatment in hepatocellular carcinoma.
BMC Cancer
September 2024
Department of Oncology, The First Affiliated Hospital of Fujian Medical University, No. 20 Chazhong Road, Fuzhou, 350005, China.
Background: Our research endeavored to develop a robust predictive signature grounded in super-enhancer-related genes (SERGs), with the dual objectives of forecasting survival outcomes and evaluating the tumor immune microenvironment (TiME) in hepatocellular carcinoma (HCC).
Methods: HCC RNA-sequencing data were retrieved from The Cancer Genome Atlas (TCGA), and 365 patients were randomly assigned to training or testing sets in 1:1 ratio. SERGs of HCC were downloaded from Super-Enhancer Database (SEdb).
Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells.
Med Oncol
August 2024
Molecular Oncology Laboratory, Department of Biochemistry, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, 620 024, India.
Breast cancer (BC) is the leading commonly diagnosed cancer in the world, with complex mechanisms underlying its development. There is an urgent need to enlighten key genes as potential therapeutic targets crucial to advancing BC treatment. This study sought to investigate the influence of doxorubicin (DOX) on identified key genes consistent across numerous BC datasets obtained through bioinformatic analysis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!